Carl E. Orringer
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 1%
- Lipoproteins and Cardiovascular Health
Papers in
- Surgery 36
- Lipoproteins and Cardiovascular Health 33
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 19
- Co-authors
- Terry A. Jacobson (11 shared papers)Kevin C. Maki (8 shared papers)Don P. Wilson (3 shared papers)Kim K. Birtcher (5 shared papers)Pamela B. Morris (4 shared papers)Christie M. Ballantyne (4 shared papers)Harold Bays (7 shared papers)Donald M. Lloyd‐Jones (4 shared papers)
- Journals
- Journal of clinical lipidology (20 papers)Journal of the American College of Cardiology (8 papers)European Heart Journal (4 papers)Current Atherosclerosis Reports (2 papers)Progress in Cardiovascular Diseases (2 papers)
- Partner nations
- United StatesTürkiyeItaly
In The Last Decade
Carl E. Orringer
52 papers receiving 3.8k citations
Carl E. Orringer's Hit Papers
Peers
Comparison fields: 5 of 119
- Endocrinology, Diabetes and Metabolism 813
- Surgery 2.1k
- Cardiology and Cardiovascular Medicine 707
- Cancer Research 275
- Emergency Medicine 158
Countries citing papers authored by Carl E. Orringer
This map shows the geographic impact of Carl E. Orringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl E. Orringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl E. Orringer more than expected).
Fields of papers citing papers by Carl E. Orringer
This network shows the impact of papers produced by Carl E. Orringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl E. Orringer. The network helps show where Carl E. Orringer may publish in the future.
Co-authors
The 25 scholars most cited alongside Carl E. Orringer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report Hit paper breakdown → | 2015 | 608 |
| 2 | National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary Hit paper breakdown → | 2014 | 379 |
| 3 | Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association Hit paper breakdown → | 2019 | 367 |
| 4 | 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk Hit paper breakdown → | 2016 | 364 |
| 5 | 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk Hit paper breakdown → | 2022 | 316 |
| 6 | 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk Hit paper breakdown → | 2017 | 290 |
| 7 | 1977 | 226 | |
| 8 | 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia Hit paper breakdown → | 2021 | 185 |
| 9 | 2020 | 133 | |
| 10 | Managing Atherosclerotic Cardiovascular Risk in Young Adults Hit paper breakdown → | 2022 | 131 |
| 11 | 2013 | 115 | |
| 12 | 2016 | 98 | |
| 13 | 2017 | 82 | |
| 14 | 2019 | 81 | |
| 15 | 2015 | 48 | |
| 16 | 1996 | 45 | |
| 17 | 2021 | 45 | |
| 18 | 2019 | 45 | |
| 19 | 2016 | 44 | |
| 20 | 2016 | 43 |
About Carl E. Orringer
Carl E. Orringer is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Economics and Econometrics, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging, having authored 55 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (33 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers), Cardiac Imaging and Diagnostics (9 papers), Cancer, Lipids, and Metabolism (6 papers), Pharmaceutical Economics and Policy (5 papers), Lipid metabolism and disorders (5 papers) and Diet and metabolism studies (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (813 citations), Surgery (2.1k citations), Cardiology and Cardiovascular Medicine (707 citations), Cancer Research (275 citations) and Emergency Medicine (158 citations). Carl E. Orringer has collaborated with scholars based in United States, Türkiye and Italy. Frequent co-authors include Terry A. Jacobson, Kevin C. Maki, Don P. Wilson, Kim K. Birtcher, Pamela B. Morris, Christie M. Ballantyne, Harold Bays, Donald M. Lloyd‐Jones, W. Virgil Brown and Margo Minissian. Their work appears in journals such as Journal of clinical lipidology, Journal of the American College of Cardiology, European Heart Journal, Current Atherosclerosis Reports and Progress in Cardiovascular Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.